Novo Nordisk Beat Expectations in Q4 and a Huge Catalyst Could Be Coming Soon
In the GLP-1 weight loss market, it's largely been a two-horse race between Eli Lilly and Novo Nordisk (NYSE: NVO). The two ...
Kingsview Wealth Management LLC Has $425,000 Position in Novo Nordisk A/S (NYSE:NVO)
Kingsview Wealth Management LLC reduced its holdings in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 76.9% during the 4th quarter, according to the company in its most recent 13F filing with ...
Swissinfo9h
Europe’s Pharma, Car Giants Most at Risk From Trump Tariffs
EU exports to the US reached $605.8 billion in 2024, according to the US Census Bureau. Pharmaceutical companies are ...
Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?
Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch.
Why Novo Nordisk Stock Keeps Going Down
Novo Nordisk (NYSE: NVO) stock is in a funk. Monday's decline probably owes to rival GLP-1 company Hims & Hers Health running ...
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...
Clinical Trials Market Size to Hit Around USD 186.09 Billion by 2034
According to Statifacts, the global clinical trials market size is calculated at USD 126.30 billion in 2025 and is expected ...
Ascendis Pharma A/S (NASDAQ:ASND) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 12, 2025 Ascendis Pharma A/S beats earnings expectations. Reported EPS is $-0.68699 ...